| 000 | 01658 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514053335.0 | ||
| 264 | 0 | _c20030113 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCui, Hongjuan | |
| 245 | 0 | 0 |
_ap53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cJul 2002 |
||
| 300 |
_a679-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCaspase 9 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclins _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome c Group _xmetabolism |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aDNA Fragmentation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEtoposide _xpharmacology |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 |
_aMitochondria _xenzymology |
| 650 | 0 | 4 |
_aNeuroblastoma _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aSchroering, Allen | |
| 700 | 1 | _aDing, Han-Fei | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 1 _gno. 9 _gp. 679-86 |
|
| 999 |
_c12284056 _d12284056 |
||